Deals and dollars to AI-based healthcare companies are on track for a record high in 2016. And increasingly, some of the most notable deals are happening outside the US.
Though 77% of the deals since 2012 have gone to US startups, there were major investments recently in other countries, including Israel, Canada, China, and India.
UK-based Babylon Health raised a $25M Series A round earlier this year from investors including Kinnevik and Google DeepMind; Khosla Ventures and Marc Benioff participated in a $12M Series B round raised by Israel-based Zebra Medical Vision; Bloomberg Beta backed Canada-based DeepGenomics in Q4’15; and that same quarter, Formation 8 and Softbank Ventures Korea seed funded South Korea-based Lunit.
This year, China-based iCarbonX joined the unicorn club in Q2’16 with early stage funding from Tencent, Vcanbio, and China Bridge Capital that valued the company at $1B. The startup, while still in its early stages of fundraising, recently acquired Imagu Vision Technology, an image processing company in Israel.
The map includes non-US heathcare AI companies that raised a funding round after January 2015, and is not meant to be exhaustive of startups in the space.
Want more data on AI-based healthcare companies? Log in to CB Insights or sign up for free below.